title: Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
authors.forename: A
authors.initials: A
authors.lastname: Ghezzi
authors.forename: M A
authors.initials: MA
authors.lastname: Rocca
authors.forename: D
authors.initials: D
authors.lastname: Baroncini
authors.forename: P
authors.initials: P
authors.lastname: Annovazzi
authors.forename: M
authors.initials: M
authors.lastname: Zaffaroni
authors.forename: G
authors.initials: G
authors.lastname: Minonzio
authors.forename: G
authors.initials: G
authors.lastname: Comi
authors.forename: M
authors.initials: M
authors.lastname: Filippi
mesh_terms: D000328:Adult; D004185:Disability Evaluation; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000008:administration & dosage*; D012008:Recurrence; D013110:Sphingosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine